JXL082
JXL082, or JXL-082, is a drug acting as a mitochondrial [pyruvate carrier] inhibitor which was synthesized towards the aim of developing a treatment for hair loss. It is related to other drugs in the same series such as PP405, JXL069, and UK-5099. The drug is known to have been sold online in a grey market fashion for treatment of hair loss. It has been mistakenly believed to be PP405, but PP405 is said not to be JXL082. JXL082 was first described in the scientific literature by 2019.